Paxlovid

The White House is unveiling a new push to make more people aware of COVID-19 treatments like Paxlovid — because stockpiles of the life-saving antiviral ...

You may click on “Your Choices” below to learn about and use cookie management tools to limit use of cookies when you visit NPR’s sites. If you click “Agree and Continue” below, you acknowledge that your cookie choices in those tools will be respected and that you otherwise agree to the use of cookies on NPR’s sites. NPR’s sites use cookies, similar tracking and storage technologies, and information about the device you use to access our sites (together, “cookies”) to enhance your viewing, listening and user experience, personalize content, personalize messages from NPR’s sponsors, provide social media features, and analyze NPR’s traffic.

April 26, 2022 – The White House is rapidly making the COVID-19 drug Paxlovid more available, as the Biden administration puts renewed emphasis on treating ...

“So far, Congress has not stepped up to provide the funds that are needed for our most urgent needs,” Jha said. “Treatments like these, vaccines we have developed, these are the key essential tools we need to get through the rest of this pandemic.” The goal of our policy should be obviously to minimize infections whenever possible and to make sure people don’t get seriously ill.” “We are, I believe, at an inflection,” Jha said at his first White House briefing since assuming his role as COVID coordinator. He continued: “We know this virus is tricky. Within the next couple of weeks, he said, they will double from 20,000 to 40,000.

Administration officials say the drug has been underused in the fight against the pandemic. Image: Pfizer Paxlovid. Pfizer's experimental antiviral drug ...

The Biden administration has been investing heavily in Paxlovid, which costs $530 for a five-day treatment. But it's unclear how many of those pills have been delivered to the federal government. It’s making sure that all over the country, in every community, providers know that we’ve got Paxlovid available for their patients.” “A lot of providers early on, in that scarcity mindset when there were fewer courses available across the country, were really reserving this for folks who they thought would be the sickest of the sick,” the senior administration official said. Still, more patients could be benefiting from the treatment, the official added. About 60 percent of adults who contract Covid would be eligible to receive the drug.

The plan is to make antivirals available at more locations, add more test-to-treat centers, and start a new awareness campaign.

The administration official said that there is no longer a limited supply of the drugs. There’s no doubt that the process of getting Paxlovid has been complicated. Senior administration officials said on a call with reporters Monday night that they would work to make sure that health care providers have the latest information on Covid treatments. Molnupiravir, developed by Merck and partner Ridgeback Biotherapeutics, interacts with fewer drugs, and was initially more widely available, but it was only 30% effective at reducing hospitalization in a large trial, although it appeared effective at preventing death. Recently, weekly courses of Paxlovid administered hit 55,000; that figure had previously been just 22,000. But it also shows very high efficacy, reducing hospitalizations and deaths by more than 89% in a large clinical trial.

The Biden administration has secured the purchase of 20 million treatment courses of Paxlovid, Pfizer's antiviral Covid-19 pill, a senior administration ...

We have a big set of efforts that we have been working on and launching, and we're going to be doing a lot more this week." "Paxlovid first became authorized by the FDA at the end of December. And there were very, very few pills around. A tranche of 100,000 courses will initially be available to pharmacies per quarter while demand and uptake are monitored.

A big announcement from the White House that the antiviral medication Paxlovid is going to be more available in more places. Health leaders say it is a game ...

What’s going to stand between life and death really is drugs like Paxlovid and some of these other drugs we have available.” Paxlovid is a COVID-fighting drug that you take orally and is designed to keep people from needing to be hospitalized or even dying. SEATTLE — A big announcement from the White House that the antiviral medication Paxlovid is going to be more available in more places.